exendin-4 tirzepatide Replacement of the C-terminal Trp-cage of with a fatty acid improves therapeutic utility Exendin-4 (1-8) | Polypeptide |

Hims & Hers has a long history of controversy over compounded GLP-1s Hims & Hers began selling copycat versions of Wegovy and Ozempic in 2024, citing a regulatory loophole that allows compounding pharmacies to copy otherwise patent-protected drugs amid shortages

The safest approach is to follow the expiration date provided and discuss this situation with your prescribing healthcare provider or pharmacist

Mounjaro: Initially approved for treating type 2 diabetes, Mounjaro is also highly effective for weight loss and is now FDA-approved for that purpose as well

Acute administration of semaglutide, tirzepatide, and retatrutide each attenuated alcohol discrimination across multiple doses, suggesting that blunting or altering subjective alcohol effects could be a common target of this drug class

The appetite hormone GLP-1 receptor, which tirzepatide activates, controls satiety signals in the brainwhen medication stops, these signals fade and eating patterns shift back toward pre-treatment levels

Results from these clinical studies demonstrated significant improvements in glycaemic control, as indicated by notable reductions in glycated haemoglobin levels (-1.87% to -2.59%, -20 to -28 mmol/mol)